PRICE AND TEST LIST January 4, 2018 (by Test Code)

Size: px
Start display at page:

Download "PRICE AND TEST LIST January 4, 2018 (by Test Code)"

Transcription

1 Test Code Test Description TAT Price 2018 CPT Codes WHOLE EXOME SEQUENCING WES001 MNG Exome TM Trio Sequencing and Copy Number Analysis + mtdna (Proband + 2 Family Members) 2-4 Weeks $6, , 81416, 81460, WES002 Additional Family Member (ony available when trio is ordered) 2-4 Weeks $2, WES003 MNG Exome TM Proband Only Sequencing and Copy Number Analysis + mtdna 2-4 Weeks $5, , 81460, CARRIER SCREENING NGS415 Ashkenazi Jewish Carrier Screen 2-4 Weeks $ , NGS416 Pan-European Carrier Screen 2-4 Weeks $1, , WES006 MNG Carrier Exome Sequencing and Copy Number Analysis + mtdna (for couples only) 2-4 Weeks $5, , HEALTHY WHOLE EXOME SEQUENCING WES007 MNG Healthy Exome Sequencing and Copy Number Analysis + mtdna 2-4 Weeks $2, RNA SEQUENCING RNA001 MNG Transcriptome 2-4 Weeks $1, RNA002 Panel-Specific RNA Sequencing 2-4 Weeks $1, RNA003 Gene-Specific RNA Sequencing Targeted Analysis 2-4 Weeks $ ENZYMOLOGY 5424 Glenridge Drive NE Atlanta, GA USA toll-free: fax: mnglabs.com CLIA License #11D ; GA License # ; MD License #1241; FL License # ; NY PFI #8159; CA License #COS When ordering tests, please use our test requisition forms available from our website at For information on contracting with us, please call and a customer service representative will direct your call. This document is subject to change at the discretion of MNG Labs, any previous versions are considered invalid. Please refer to for the newest version. VISIT TO SUBMIT QUESTIONS BY SECURE HIPAA-COMPLIANT . VISIT FOR DESCRIPTIONS OF EACH TEST, AS WELL AS MOLECULAR DIFFERENTIAL DIAGNOSIS SEARCH. ORDER TEST KITS ONLINE AT FOR SIMPLIFIED SAMPLE PROCESSING, AND FREE INBOUND AND RETURN SHIPPING. (WE GLADLY ACCEPT DELIVERIES MONDAY-SATURDAY, EXCLUDING HOLIDAYS.) CPT codes provided here are for reference purpose only. They are not an assurance of approval nor reimbursement. PRICE AND TEST LIST January 4, 2018 (by Test Code) FULLTESTLIST.23 1 of 16

2 ENZ01 Aromatic L-amino Acid Decarboxylase Enzyme Analysis (Plasma) 3 Weeks $ , ENZ06 Thymidine Phosphorylase Enzyme Analysis (Blood) 3 Weeks $ METABOLIC ANALYSES MET01 Amino Acids (CSF) Days $ MET02 Amino Acids (Plasma) Days $ MET03 Amino Acids (Urine) Days $ MET04 Coenzyme Q10 (Leukocytes) Days $ MET05 Coenzyme Q10 (Muscle) Days $ MET07 Lactate (CSF) Days $ MET08 Lactate (plasma) Days $ MET09 Phenylalanine Loading Assay (Plasma) Days $ MET10 Pyruvate (Blood) Days $ MET11 Pyruvate (CSF) Days $ MET12 Thymidine/Deoxyuridine Analytes (Plasma) Days $ MET19 Creatine and Guanidinoacetate (Urine) Days $ MET20 Alpha Aminoadipic Semialdehyde (Urine) Days $ MET21 Sialic Acid (Urine) Days $ MET22 Folate Receptor Antibody Assay (Plasma/Serum) Days $ MET23 Creatine and Guanidinoacetate (Plasma) Days $ MET24 Glucose (Plasma) Days $ MET25 Folate Receptor Antibody Assay (CSF) Days $ MET29 3-O-Methyldopa (Plasma) Days $ GENE SEQUENCING (SANGER), DELETION/DUPLICATION (MLPA), POINT MUTATIONS - INDIVIDUAL GENES & PANELS MOL001 Mitochondrial DNA Depletion Testing (Muscle) 2-4 Weeks $ MOL002 Mitochondrial DNA Deletion Analysis 2-4 Weeks $ MOL021 Mitochondrial Genome Sequencing 2-4 Weeks $ MOL022 HADHA Mutation Screen: c.1528g>c, E510Q 2-4 Weeks $ MOL023 ACADM Mutation Screen: c.985a>g, K329E 2-4 Weeks $ MOL024 PYGM Mutation Screen: c.148c>t, R50X; c.613g>a, G205S; c.1628a>c, K543T 2-4 Weeks $ MOL025 DDC Full Gene Sequencing Analysis 2-4 Weeks $ MOL026 ABCB7 Full Gene Sequencing Analysis 2-4 Weeks $ MOL027 ACADM Full Gene Sequencing Analysis 2-4 Weeks $ MOL028 ACADS Full Gene Sequencing Analysis 2-4 Weeks $ of 16

3 MOL029 ACADVL Full Gene Sequencing Analysis 2-4 Weeks $ MOL030 ALDH7A1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL031 SLC25A4 Full Gene Sequencing Analysis 2-4 Weeks $ MOL032 ATP1A2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL033 CACNA1A Full Gene Sequencing Analysis 2-4 Weeks $1, MOL034 CAPN3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL035 CAV3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL036 NDUFS1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL037 NDUFS4 Full Gene Sequencing Analysis 2-4 Weeks $ MOL038 NDUFS7 Full Gene Sequencing Analysis 2-4 Weeks $ MOL039 NDUFS8 Full Gene Sequencing Analysis 2-4 Weeks $ MOL040 NDUFV1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL041 SDHA Full Gene Sequencing Analysis 2-4 Weeks $ MOL042 SDHB Full Gene Sequencing Analysis 2-4 Weeks $ MOL043 SDHC Full Gene Sequencing Analysis 2-4 Weeks $ MOL044 SDHD Full Gene Sequencing Analysis 2-4 Weeks $ MOL045 BCS1L Full Gene Sequencing Analysis 2-4 Weeks $ MOL046 COQ2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL047 COX10 Full Gene Sequencing Analysis 2-4 Weeks $ MOL048 COX15 Full Gene Sequencing Analysis 2-4 Weeks $ MOL049 CPT1A Full Gene Sequencing Analysis 2-4 Weeks $ MOL050 CPT2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL051 DGUOK Full Gene Sequencing Analysis 2-4 Weeks $ MOL052 DYSF Full Gene Sequencing Analysis 2-4 Weeks $1, MOL053 TYMP Full Gene Sequencing Analysis 2-4 Weeks $ MOL054 EIF2B1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL055 EIF2B2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL056 EIF2B3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL057 EIF2B4 Full Gene Sequencing Analysis 2-4 Weeks $ MOL058 EIF2B5 Full Gene Sequencing Analysis 2-4 Weeks $ MOL059 FXN Full Gene Sequencing Analysis 2-4 Weeks $ MOL060 GCH1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL061 GYS2 Full Gene Sequencing Analysis 2-4 Weeks $ of 16

4 MOL062 HADHA Full Gene Sequencing Analysis 2-4 Weeks $ MOL063 HADHB Full Gene Sequencing Analysis 2-4 Weeks $ MOL064 KCNA1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL065 LAMA2 Full Gene Sequencing Analysis 2-4 Weeks $1, MOL066 LMNA Full Gene Sequencing Analysis 2-4 Weeks $ MOL067 MECP2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL068 MPV17 Full Gene Sequencing Analysis 2-4 Weeks $ MOL069 OPA1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL070 PDHA1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL071 PDSS1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL072 PDSS2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL073 C10ORF2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL074 PNPO Full Gene Sequencing Analysis 2-4 Weeks $ MOL075 POLG Full Gene Sequencing Analysis 2-4 Weeks $ MOL076 PYGM Full Gene Sequencing Analysis 2-4 Weeks $ MOL077 RRM2B Full Gene Sequencing Analysis 2-4 Weeks $ MOL078 SGCA Full Gene Sequencing Analysis 2-4 Weeks $ MOL079 SGCB Full Gene Sequencing Analysis 2-4 Weeks $ MOL080 SGCD Full Gene Sequencing Analysis 2-4 Weeks $ MOL081 SGCG Full Gene Sequencing Analysis 2-4 Weeks $ MOL082 SCO1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL083 SCO2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL085 SLC25A20 Full Gene Sequencing Analysis 2-4 Weeks $ MOL086 HSPD1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL087 SPG7 Full Gene Sequencing Analysis 2-4 Weeks $ MOL088 SUCLA2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL089 SUCLG1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL090 SURF1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL091 TH Full Gene Sequencing Analysis 2-4 Weeks $ MOL092 TPH2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL093 UBE3A Full Gene Sequencing Analysis 2-4 Weeks $ MOL094 DARS2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL095 SLC18A2 Full Gene Sequencing Analysis 2-4 Weeks $ of 16

5 MOL096 PTS Full Gene Sequencing Analysis 2-4 Weeks $ MOL097 SLC6A3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL098 TIMM8A Full Gene Sequencing Analysis 2-4 Weeks $ MOL099 MRPS16 Full Gene Sequencing Analysis 2-4 Weeks $ MOL100 UQCRB Full Gene Sequencing Analysis 2-4 Weeks $ MOL101 NDUFAF2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL102 NDUFA1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL103 NDUFS2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL104 NDUFS3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL105 NDUFV2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL106 NDUFAF1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL107 PUS1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL108 TUFM Full Gene Sequencing Analysis 2-4 Weeks $ MOL109 POLG2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL110 APTX Full Gene Sequencing Analysis 2-4 Weeks $ MOL111 TAZ Full Gene Sequencing Analysis 2-4 Weeks $ MOL112 ATPAF2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL113 GFM1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL114 MFN2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL115 LRPPRC Full Gene Sequencing Analysis 2-4 Weeks $ MOL116 GLRA1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL117 QDPR Full Gene Sequencing Analysis 2-4 Weeks $ MOL118 RNASEH2B Full Gene Sequencing Analysis 2-4 Weeks $ MOL119 TREX1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL120 GLRB Full Gene Sequencing Analysis 2-4 Weeks $ MOL121 SLC2A1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL122 GFAP Full Gene Sequencing Analysis 2-4 Weeks $ MOL124 RNASEH2A Full Gene Sequencing Analysis 2-4 Weeks $ MOL125 ALDH5A1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL126 SPR Full Gene Sequencing Analysis 2-4 Weeks $ MOL127 SLC6A5 Full Gene Sequencing Analysis 2-4 Weeks $ MOL128 COQ3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL129 COQ4 Full Gene Sequencing Analysis 2-4 Weeks $ of 16

6 MOL131 COQ6 Full Gene Sequencing Analysis 2-4 Weeks $ MOL132 COQ7 Full Gene Sequencing Analysis 2-4 Weeks $ MOL133 COQ9 Full Gene Sequencing Analysis 2-4 Weeks $ MOL137 TPM3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL138 ZMPSTE24 Full Gene Sequencing Analysis 2-4 Weeks $ MOL139 MTM1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL140 ADCK3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL141 DBH Full Gene Sequencing Analysis 2-4 Weeks $ MOL142 ETFDH Full Gene Sequencing Analysis 2-4 Weeks $ MOL143 POMT2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL144 MYOT Full Gene Sequencing Analysis 2-4 Weeks $ MOL145 EMD Full Gene Sequencing Analysis 2-4 Weeks $ MOL146 HCCS Full Gene Sequencing Analysis 2-4 Weeks $ MOL147 BRAF Full Gene Sequencing Analysis 2-4 Weeks $ MOL148 TCAP Full Gene Sequencing Analysis 2-4 Weeks $ MOL149 FKRP Full Gene Sequencing Analysis 2-4 Weeks $ MOL150 FKTN Full Gene Sequencing Analysis 2-4 Weeks $ MOL151 NDUFAF5 Full Gene Sequencing Analysis 2-4 Weeks $ MOL152 RARS2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL153 POMT1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL154 RYR1 Full Gene Sequencing and Copy Number Analysis 2-4 Weeks $1, MOL155 GFER Full Gene Sequencing Analysis 2-4 Weeks $ MOL156 TMEM126A Full Gene Sequencing Analysis 2-4 Weeks $ MOL157 NDUFS6 Full Gene Sequencing Analysis 2-4 Weeks $ MOL158 NDUFAF3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL159 TNNI2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL160 NDUFA2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL161 NDUFA11 Full Gene Sequencing Analysis 2-4 Weeks $ MOL162 NDUFAF4 Full Gene Sequencing Analysis 2-4 Weeks $ MOL163 ETFA Full Gene Sequencing Analysis 2-4 Weeks $ MOL164 ETFB Full Gene Sequencing Analysis 2-4 Weeks $ MOL165 FASTKD2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL166 FOLR1 Full Gene Sequencing Analysis 2-4 Weeks $ of 16

7 MOL167 GARS Full Gene Sequencing Analysis 2-4 Weeks $ MOL168 RNASEH2C Full Gene Sequencing Analysis 2-4 Weeks $ MOL169 SLC25A19 Full Gene Sequencing Analysis 2-4 Weeks $ MOL170 SLC17A5 Full Gene Sequencing Analysis 2-4 Weeks $ MOL171 MTHFR Full Gene Sequencing Analysis 2-4 Weeks $ MOL172 SAMHD1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL173 TMEM70 Full Gene Sequencing Analysis 2-4 Weeks $ MOL174 UQCRQ Full Gene Sequencing Analysis 2-4 Weeks $ MOL177 Vanishing White Matter Disease Full Gene Sequencing Analysis Panel (5 Genes) 2-4 Weeks $1, MOL179 Sarcoglycan Full Gene Sequencing Analysis Panel (4 Genes) 2-4 Weeks $1, MOL180 Hyperekplexia Full Gene Sequencing Analysis Panel (5 Genes) 2-4 Weeks $1, MOL182 COX6B1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL183 AIFM1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL184 PHOX2B Full Gene Sequencing Analysis 2-4 Weeks $ MOL185 AMPD1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL186 SLC2A1 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL187 MECP2 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL189 Mitochondrial Genome Sequencing + Deletion Analysis 2-4 Weeks $1, , MOL208 CACNA1A Copy Number Analysis 2-4 Weeks $ MOL209 ADSL Full Gene Sequencing Analysis 2-4 Weeks $ MOL210 FOXRED1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL211 NUBPL Full Gene Sequencing Analysis 2-4 Weeks $ MOL212 GLDC Full Gene Sequencing Analysis 2-4 Weeks $ MOL213 GCDH Full Gene Sequencing 2-4 Weeks $ MOL214 ATP1A2 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL215 GCH1 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL216 KCNQ2 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL217 PDHA1 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL218 SCN1A MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL219 GLDC MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL222 PDHB Full Gene Sequencing Analysis 2-4 Weeks $ MOL223 PDP1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL224 DLAT Full Gene Sequencing Analysis 2-4 Weeks $ of 16

8 MOL225 DLD Full Gene Sequencing Analysis 2-4 Weeks $ MOL226 PC Full Gene Sequencing Analysis 2-4 Weeks $ MOL227 CACNB4 Full Gene Sequencing Analysis 2-4 Weeks $ MOL228 SLC1A3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL229 KCNQ2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL230 SCN1A Full Gene Sequencing Analysis 2-4 Weeks $ MOL231 SLC2A1 Full Gene Sequencing + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL232 Mitochondrial Genome Sequencing + Deletion Analysis + Depletion Testing (Leukocyte) 2-4 Weeks $1, , 81465, MOL233 SLC12A3 Full Gene Sequencing Analysis 2-4 Weeks $ MOL234 GCH1 Full Gene Sequencing + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL235 PDHA1 Full Gene Sequencing + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL236 GLDC Full Gene Sequencing + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, MOL237 DHFR Full Gene Sequencing Analysis 2-4 Weeks $ MOL238 FOXP2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL239 CAPN3 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL240 CAPN3 Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL241 TACO1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL242 ACAD8 Full Gene Sequencing Analysis 2-4 Weeks $ MOL243 ACAD9 Full Gene Sequencing Analysis 2-4 Weeks $ MOL244 SLC12A3 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL245 SLC12A3 Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL246 SLC6A8 Full Gene Sequencing Analysis 2-4 Weeks $ MOL247 SGCE Full Gene Sequencing Analysis 2-4 Weeks $ MOL248 SCN1A Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL249 Known Familial Mutation (KFM) Analysis (each mutation) 2-4 Weeks $ , MOL250 MPZ Full Gene Sequencing Analysis 2-4 Weeks $ MOL251 GPHN Full Gene Sequencing Analysis 2-4 Weeks $ MOL252 SLC6A4 Full Gene Sequencing Analysis 2-4 Weeks $ MOL253 PGAM2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL254 CHKB Full Gene Sequencing Analysis 2-4 Weeks $ MOL255 SCN1B Full Gene Sequencing Analysis 2-4 Weeks $ MOL256 SPAST Full Gene Sequencing Analysis 2-4 Weeks $ MOL257 MECP2 Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , of 16

9 MOL258 SCN9A Full Gene Sequencing 2-4 Weeks $ MOL259 Friedreich Ataxia Genetic Testing (Repeat Expansion) 2-4 Weeks $ MOL260 ACADVL MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL261 ACADVL Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL262 SLC22A5 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL264 SPAST MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL265 SPAST Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL266 ATL1/SPG3 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL267 ATL1/SPG3 Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL268 CLCNKA Full Gene Sequencing Analysis 2-4 Weeks $ MOL270 KCNJ1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL271 BSND Full Gene Sequencing Analysis 2-4 Weeks $ MOL272 PFKM Full Gene Sequencing Analysis 2-4 Weeks $ MOL274 PDXK Full Gene Sequencing Analysis 2-4 Weeks $ MOL276 PMP22 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL277 GJB1 (CX32) MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL278 MPZ MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL281 DOK7 Full Gene Sequencing Analysis 2-4 Weeks $ MOL282 SGCE MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL283 SGCE Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL285 Hyperekplexia Copy Number Analysis 2-4 Weeks $ MOL286 CLCNKB MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL287 CLCNKB Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, MOL289 MTM1 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL290 MTM1 Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL291 OPA1 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL292 OPA1 Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL293 MFN2 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL294 POLG MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL295 ATP5E Full Gene Sequencing Analysis 2-4 Weeks $ MOL297 Hyperekplexia Full Gene Sequencing Analysis Panel (5 Genes) + Copy Number Analysis 2-4 Weeks $1, MOL299 Myotonic Dystrophy 1 (DMPK) Genetic Testing (Repeat Expansion) 2-4 Weeks $ MOL301 Spinal Muscular Atrophy (SMN1/SMN2) MLPA Duplication/Deletion Analysis 2-4 Weeks $ of 16

10 MOL302 Dystrophin MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL303 Myotonic Dystrophy 2 (ZNF9/CNBP) Genetic Testing (Repeat Expansion) 2-4 Weeks $ MOL305 TK2 Full Gene Sequencing Analysis 2-4 Weeks $ MOL306 ARHGEF9 Full Gene Sequencing Analysis 2-4 Weeks $ MOL307 CACNA1S Full Gene Sequencing Analysis 2-4 Weeks $1, MOL308 GLUL Full Gene Sequencing Analysis 2-4 Weeks $ MOL309 ADAR Full Gene Sequencing Analysis 2-4 Weeks $ MOL313 C10ORF2 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL314 FKRP MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL315 GARS MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL316 HSPB1 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL317 LAMA2 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL318 MPV17 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL319 NEFL MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL320 PRX MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL321 RAB7A MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL322 RRM2B MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL323 Sarcoglycan Panel MLPA Duplication/Deletion Analysis (4 Genes) 2-4 Weeks $1, MOL324 SGCA MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL325 SGCB MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL326 SGCD MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL327 SGCG MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL328 SLC25A4 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL329 TK2 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL330 KCNQ2 Full Gene Sequencing + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL331 SPTLC1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL332 GJB1 (CX32) Full Gene Sequencing Analysis 2-4 Weeks $ MOL333 GJB1 (CX32) Full Gene Sequencing + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL334 Mitochondrial DNA Depletion Testing (Leukocyte) 2-4 Weeks $ MOL335 LITAF Full Gene Sequencing Analysis 2-4 Weeks $ MOL336 SEPT9 Full Gene Sequencing Analysis 2-4 Weeks $ MOL339 DARS Full Gene Sequencing Analysis 2-4 Weeks $ MOL340 Mitochondrial Genome Sequencing + Deletion Analysis + Depletion Testing (Muscle) 2-4 Weeks $1, , 81465, of 16

11 MOL341 GNE Full Gene Sequencing Analysis 2-4 Weeks $ MOL342 DPYS Full Gene Sequencing Analysis 2-4 Weeks $ MOL343 SPG11 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL344 PMP22 Full Gene Sequencing Analysis 2-4 Weeks $ MOL345 PMP22 Full Gene Sequencing + MLPA Duplication/Deletion Analysis 2-4 Weeks $1, , MOL346 SCN10A Full Gene Sequencing Analysis 2-4 Weeks $ MOL347 SCN11A Full Gene Sequencing Analysis 2-4 Weeks $ MOL348 SCN5A Full Gene Sequencing Analysis 2-4 Weeks $ MOL349 PAH Full Gene Sequencing Analysis 2-4 Weeks $ MOL350 PKD1/PKD2 MLPA Duplication/Deletion Analysis 2-4 Weeks $ MOL351 GAMT Full Gene Sequencing Analysis 2-4 Weeks $ MOL352 GATM Full Gene Sequencing Analysis 2-4 Weeks $ MOL354 DEPDC5 Full Gene Sequencing Analysis 2-4 Weeks $ MOL355 CLCN1 Full Gene Sequencing Analysis 2-4 Weeks $ MOL356 SCN4A Full Gene Sequencing Analysis 2-4 Weeks $ MOL358 Hyperphenylalaninemia Full Gene Sequencing Analysis Panel (5 Genes) 2-4 Weeks $1, , 81406, MOL359 Creatine Metabolism Full Gene Sequencing Analysis Panel (3 Genes) 2-4 Weeks $1, MOL360 PEX6 Full Gene Sequencing Analysis 2-4 Weeks $ MOL362 TUBB4A Full Gene Sequencing Analysis 2-4 Weeks $ MOL364 C9orf72 Repeat Expansion Analysis 2-4 Weeks $ MOL366 Huntington Disease: HTT Repeat Expansion Analysis 2-4 Weeks $ MOL367 PROSC Full Gene Sequencing Analysis 2-4 Weeks $ MOL379 Spinocerebellar Ataxia Repeat Panel (SCA 8, 10, 12, 17, 36, & DRPLA) 2-4 Weeks $ MOL380 Comprehensive Spinocerebellar Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, & DRPLA) 2-4 Weeks $ MOL381 Fragile X Repeat Expansion + Methylation Analysis 2-4 Weeks $ , NEUROCHEMISTRY ANALYSES NC01 5-Methyltetrahydrofolate (CSF) Days $ NC02 Neopterin (CSF) Days $ NC03 Neopterin/Tetrahydrobiopterin (CSF) Days $ NC04 Neurotransmitter Metabolites (5HIAA, HVA, 3OMD) (CSF) Days $ , 83497, NC05 Pyridoxal 5'-phosphate (CSF) Days $ NC06 Succinyladenosine (CSF) Days $ NC07 Sialic Acid (CSF) Days $ of 16

12 NC08 Alpha-aminoadipic Semialdehyde (CSF) Days $ NC09 4-Hydroxybutyric Acid (CSF) Days $ NC10 Glucose (CSF) Days $ NEXT GENERATION SEQUENCING (NGS) PANELS NGS197 Coenzyme Q10 Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 12 Genes) 2-4 Weeks $1, , 81405, NGS198 Comprehensive mtdna Depletion Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 17 Genes) 2-4 Weeks $1, , 81465, NGS301 Comprehensive Cellular Energetics Defects (NextGen Sequencing Panel and Copy Number Analysis; 343 Genes + mtdna) 2-4 Weeks $2, , 81460, NGS302 Carbohydrate Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 47 Genes + mtdna) 2-4 Weeks $1, , 81465, NGS303 Lipid Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 46 Genes + mtdna) 2-4 Weeks $1, , 81465, NGS304 Pyruvate Metabolism Disorders (NextGen Sequencing Panel and Copy Number Analysis; 14 Genes + mtdna) 2-4 Weeks $1, , 81465, 81405, x3 NGS305 PDH/Tricarboxylic Acid Cycle (TCA) Defects (NextGen Sequencing Panel and Copy Number Analysis; 23 Genes + mtdna) 2-4 Weeks $1, , 81465, 81405, x3 NGS306 Oxidative Phosphorylation (OXPHOS) Defects (NextGen Sequencing Panel and Copy Number Analysis; 193 Genes + mtdna) 2-4 Weeks $2, , 81465, NGS307 Ceroid Lipofuscinosis Disorders (NextGen Sequencing Panel and Copy Number Analysis; 13 Genes) 2-4 Weeks $1, , NGS308 Creatine Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 3 Genes) 2-4 Weeks $1, NGS309 Cobalamin/Homocysteine/Methionine Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 19 Genes) 2-4 Weeks $1, NGS310 GABA Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 16 Genes) 2-4 Weeks $1, NGS311 Glutaric Acidemia Disorders (NextGen Sequencing Panel and Copy Number Analysis; 8 Genes) 2-4 Weeks $1, , NGS312 Ketone Body Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 5 Genes) 2-4 Weeks $1, NGS313 Lysosomal Disease (NextGen Sequencing Panel and Copy Number Analysis; 72 Genes) 2-4 Weeks $1, , x4, NGS314 Methylmalonic Acid Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 13 Genes) 2-4 Weeks $1, x2, 81406, NGS315 Neurotransmitter Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 62 Genes) 2-4 Weeks $2, NGS316 Dopamine Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 13 Genes) 2-4 Weeks $1, NGS317 Serotonin Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 12 Genes) 2-4 Weeks $1, NGS318 Tetrahydrofolate Metabolism Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 8 Genes) 2-4 Weeks $1, NGS319 Fever Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 36 Genes) 2-4 Weeks $1, , NGS320 Tyrosinemia (NextGen Sequencing Panel and Copy Number Analysis; 3 Genes) 2-4 Weeks $1, , NGS321 Urea Cycle Disorders (NextGen Sequencing Panel and Copy Number Analysis; 16 Genes) 2-4 Weeks $1, , 81406, NGS323 Amyotrophic Lateral Sclerosis (NextGen Sequencing Panel and Copy Number Analysis; 28 Genes) 2-4 Weeks $1, , 81405, 81406, NGS324 Ataxia/Episodic Ataxia Disorders (NextGen Sequencing Panel and Copy Number Analysis; 362 Genes + mtdna) 2-4 Weeks $2, NGS325 Comprehensive Intellectual Disability (NextGen Sequencing Panel and Copy Number Analysis; 902 Genes) 2-4 Weeks $2, , 81465, x1, x2, x2, x1, x1, , 81471, 81302, 81304, 81404, 81405, x2 NGS327 Congenital Glycosylation Disorders (NextGen Sequencing Panel and Copy Number Analysis; 45 Genes) 2-4 Weeks $1, NGS330 Comprehensive Muscular Dystrophy/Myopathy (NextGen Sequencing Panel and Copy Number Analysis; 460 Genes + mtdna) 2-4 Weeks $2, , 81465, 81479, 81161, x6, x2, x3 12 of 16

13 NGS331 Congenital Myasthenic Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 17 Genes) 2-4 Weeks $1, , NGS332 Hypokalemic and Hyperkalemic Periodic Paralysis Disorders (NextGen Sequencing Panel and Copy Number Analysis; 7 Genes) 2-4 Weeks $1, , NGS333 Malignant Hyperthermia (NextGen Sequencing Panel and Copy Number Analysis; 2 Genes) 2-4 Weeks $1, , NGS335 Neurofibromatosis (NextGen Sequencing Panel and Copy Number Analysis; 21 Genes) 2-4 Weeks $1, , 81408, NGS337 Spastic Paraplegia (NextGen Sequencing Panel and Copy Number Analysis; 262 Genes + mtdna) 2-4 Weeks $1, , 81465, 81404, 81405, x3, 81407, NGS343 Peroxisomal Disease (NextGen Sequencing Panel and Copy Number Analysis; 32 Genes) 2-4 Weeks $1, NGS344 Aicardi-Goutieres Syndrome (NextGen Sequencing Panel and Copy Number Analysis; 7 Genes) 2-4 Weeks $1, NGS345 Charcot-Marie-Tooth Disease (NextGen Sequencing Panel and Copy Number Analysis; 189 Genes + mtdna) 2-4 Weeks $2, NGS345A Charcot-Marie-Tooth Disease, Axonal (NextGen Sequencing Panel and Copy Number Analysis; 113 Genes + mtdna) 2-4 Weeks $1, NGS345D Charcot-Marie-Tooth Disease, Demyelinating (NextGen Sequencing Panel and Copy Number Analysis; 143 Genes + mtdna) 2-4 Weeks $1, , 81465, 81324, 81325, x3, x4, x , 81465, 81324, 81325, x3, x4, x , 81465, 81324, 81325, x3, x4, x3 NGS346 Hereditary Sensory & Autonomic Neuropathy (NextGen Sequencing Panel and Copy Number Analysis; 117 Genes) 2-4 Weeks $1, NGS347 Spinal Muscular Atrophy (NextGen Sequencing Panel and Copy Number Analysis; 21 Genes) 2-4 Weeks $1, , NGS348 Fetal Akinesia, Arthrogryposis, or Contractures (NextGen Sequencing Panel and Copy Number Analysis; 153 Genes) 2-4 Weeks $2, NGS349 Nonsyndromic Intellectual Disability (NextGen Sequencing Panel and Copy Number Analysis; 243 Genes) 2-4 Weeks $1, , 81406, NGS350 Syndromic Intellectual Disability (NextGen Sequencing Panel and Copy Number Analysis; 686 Genes) 2-4 Weeks $1, , 81304, 81404, 81405, NGS351 Leigh Disease (NextGen Sequencing Panel and Copy Number Analysis; 74 Genes + mtdna) 2-4 Weeks $1, , 81465, 81404, x7, x2, NGS352 Comprehensive Ophthalmoplegia Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 55 Genes + mtdna) 2-4 Weeks $1, , 81406, 81460, 81465, NGS353 Cellular Energetics Ophthalmoplegia Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 22 Genes + mtdna) 2-4 Weeks $1, , 81460, 81405, 81406, NGS354 Non-mitochondrial Comprehensive Ophthalmoplegia Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 32 Genes) 2-4 Weeks $1, NGS355 Cytochrome C Oxidase Deficiency (NextGen Sequencing Panel and Copy Number Analysis; 44 Genes + mtdna) 2-4 Weeks $1, , 81465, x2, x3, NGS356 Alzheimer Disease/Frontotemporal Dementia (NextGen Sequencing Panel and Copy Number Analysis; 40 Genes) 2-4 Weeks $1, , 81405, x2, NGS357 Parkinson's Disease/Parkinsonism (NextGen Sequencing Panel and Copy Number Analysis; 75 Genes) 2-4 Weeks $1, , 81406, NGS358 Comprehensive Dystonia (NextGen Sequencing Panel and Copy Number Analysis; 192 Genes + mtdna) 2-4 Weeks $1, , 81465, 81479, x2, x2, NGS359 Primary Dystonia (NextGen Sequencing Panel and Copy Number Analysis; 20 Genes) 2-4 Weeks $1, NGS360 Basal Ganglia Calcification Dystonia (NextGen Sequencing Panel and Copy Number Analysis; 23 Genes) 2-4 Weeks $1, NGS361 OXPHOS Defect Dystonia (NextGen Sequencing Panel and Copy Number Analysis; 43 Genes + mtdna) 2-4 Weeks $1, , 81465, NGS362 Neurodegeneration with Brain Iron Accumulation (NextGen Sequencing Panel and Copy Number Analysis; 10 Genes) 2-4 Weeks $1, NGS363 Comprehensive Cardiomyopathy (NextGen Sequencing Panel and Copy Number Analysis; 129 Genes + mtdna) 2-4 Weeks $2, , 81460, NGS364 Left Ventricular Noncompaction Cardiomyopathy Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 7 Genes) 2-4 Weeks $1, , NGS365 Hereditary Cardiac Arrhythmia (NextGen Sequencing Panel and Copy Number Analysis; 60 Genes) 2-4 Weeks $1, , of 16

14 NGS366 Hereditary Ventricular Tachycardia Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 28 Genes) 2-4 Weeks $1, x2, x2, 81408, NGS367 Arrhythmogenic Right Ventricular Dysplasia (NextGen Sequencing Panel and Copy Number Analysis; 10 Genes) 2-4 Weeks $1, , NGS368 Long and Short QT Syndrome (NextGen Sequencing Panel and Copy Number Analysis; 16 Genes) 2-4 Weeks $1, , 81404, 81406, NGS369 Brugada Syndrome (NextGen Sequencing Panel and Copy Number Analysis; 12 Genes) 2-4 Weeks $1, , NGS370 Congenital Heart Defects (NextGen Sequencing Panel and Copy Number Analysis; 101 Genes) 2-4 Weeks $1, , x3, NGS371 Congenital Central Hypoventilation Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 7 Genes) 2-4 Weeks $1, , NGS372 Comprehensive Leukodystrophy/Leukoencephalopathy (NextGen Sequencing Panel and Copy Number Analysis; 122 Genes + mtdna) 2-4 Weeks $2, ,81465, x2, x3, NGS373 Non-Mitochondrial Leukodystrophy/Leukoencephalopathy (NextGen Sequencing Panel and Copy Number Analysis; 53 Genes) 2-4 Weeks $1, x2, x3, NGS374 Mitochondrial Leukodystrophy/Leukoencephalopathy (NextGen Sequencing Panel and Copy Number Analysis; 44 Genes + mtdna) 2-4 Weeks $1, , 81460, NGS375 Vanishing White Matter, Dysmyelinating, and Hypomyelinating Leukodystrophy (NextGen Sequencing Panel and Copy Number Analysis; 62 Genes) 2-4 Weeks $1, , x3, NGS376 Comprehensive Dementia (NextGen Sequencing Panel and Copy Number Analysis; 95 Genes) 2-4 Weeks $1, , 81404, x2, x3 NGS377 Ehlers Danlos, Ehlers Danlos-like Syndromes, and Aneurysm Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 46 Genes) 2-4 Weeks $1, x2, NGS378 Marfan and Marfan-like Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 17 Genes) 2-4 Weeks $1, , NGS379 Polycystic Kidney Disease (NextGen Sequencing Panel and Copy Number Analysis; 4 Genes) 2-4 Weeks $1, NGS380 Amyloid Related Disorders (NextGen Sequencing Panel and Copy Number Analysis; 17 Genes) 2-4 Weeks $1, x2, NGS381 Mucopolysaccharidosis and Mucolipid Disorders (NextGen Sequencing Panel and Copy Number Analysis; 13 Genes) 2-4 Weeks $1, , 81406, NGS383 Comprehensive Metabolic Disease Hepatomegaly (NextGen Sequencing Panel and Copy Number Analysis; 79 Genes + mtdna) 2-4 Weeks $1, NGS384 Carbohydrate Metabolism Hepatomegaly (NextGen Sequencing Panel and Copy Number Analysis; 11 Genes) 2-4 Weeks $1, NGS385 Comprehensive Epilepsy (NextGen Sequencing Panel and Copy Number Analysis; 554 Genes + mtdna) 2-4 Weeks $2, , 81465, x2, x3, x1, NGS386 Epileptic Encephalopathy (NextGen Sequencing Panel and Copy Number Analysis; 137 Genes) 2-4 Weeks $1, , 81304, x2, 81407, NGS387 Comprehensive Neuronal Migration Disorders (NextGen Sequencing Panel and Copy Number Analysis; 182 Genes + mtdna) 2-4 Weeks $2, , NGS388 Non-Mitochondrial Neuronal Migration Disorders (NextGen Sequencing Panel and Copy Number Analysis; 98 Genes) 2-4 Weeks $1, , NGS389 Mitochondrial Neuronal Migration Disorders (NextGen Sequencing Panel and Copy Number Analysis; 11 Genes + mtdna) 2-4 Weeks $1, , NGS392 Bartter/Gitelman Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 8 Genes) 2-4 Weeks $1, , 81406, x2, NGS393 Maple Syrup Urine Disease (NextGen Sequencing Panel and Copy Number Analysis; 4 Genes) 2-4 Weeks $1, , x2, NGS394 Joubert Syndrome (NextGen Sequencing Panel and Copy Number Analysis; 21 Genes) 2-4 Weeks $1, x2, NGS395 Meckel Syndrome (NextGen Sequencing Panel and Copy Number Analysis; 11 Genes) 2-4 Weeks $1, , 81408, NGS396 Porphyria Disorders (NextGen Sequencing Panel and Copy Number Analysis; 11 Genes) 2-4 Weeks $1, NGS397 Osteogenesis Imperfecta (NextGen Sequencing Panel and Copy Number Analysis; 13 Genes) 2-4 Weeks $1, x2, NGS398 Macrocephaly and Overgrowth Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 125 Genes) 2-4 Weeks $1, , 81304, 81405, x3, 81407, 81408, NGS399 Heterotaxy Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 7 Genes) 2-4 Weeks $1, NGS400 Pain Syndromes (NextGen Sequencing Panel and Copy Number Analysis; 16 Genes) 2-4 Weeks $1, of 16

15 NGS401 Stickler Syndrome (NextGen Sequencing Panel and Copy Number Analysis; 5 Genes) 2-4 Weeks $1, NGS402 Usher Syndrome (NextGen Sequencing Panel and Copy Number Analysis; 12 Genes) 2-4 Weeks $1, , x2, x2 NGS404 Hypothyroidism (NextGen Sequencing Panel and Copy Number Analysis; 7 Genes) 2-4 Weeks $1, NGS405 Amyotrophic Lateral Sclerosis (NextGen Sequencing Panel and Copy Number Analysis; 28 Genes +C9orf72 Repeat Expansion Analysis) 2-4 Weeks $1, , 81405, 81406, x2 NGS406 Alzheimer Disease/Frontotemporal Dementia (NextGen Sequencing Panel and Copy Number Analysis; 40 Genes + C9orf72 Repeat Expansion Analysis) 2-4 Weeks $2, , 81405, x2, x2 NGS407 Comprehensive Dementia (NextGen Sequencing Panel and Copy Number Analysis; 95 Genes + C9orf72 Repeat Expansion Analysis) 2-4 Weeks $2, x2, 81404, x2, x3 NGS408 Ataxia/Episodic Ataxia Disorders (NextGen Sequencing Panel and Copy Number Analysis; 362 Genes + mtdna + HTT Repeat Expansion Analysis) 2-4 Weeks $2, NGS409 Comprehensive Dystonia (NextGen Sequencing Panel and Copy Number Analysis; 192 Genes + mtdna + HTT Repeat Expansion Analysis) 2-4 Weeks $2, NGS410 Comprehensive Dementia (NextGen Sequencing Panel and Copy Number Analysis; 95 Genes + HTT Repeat Expansion Analysis) 2-4 Weeks $2, NGS411 Comprehensive Dementia (NextGen Sequencing Panel and Copy Number Analysis; 95 Genes + C9orf72 & HTT Repeat Expansion Analysis) 2-4 Weeks $2, , 81465, x1, x2, x2, x1, x1, 81479, , 81465, x2, x2, x2, , 81479, 81404, x2, x , x2, 81404, x2, x3 NGS412 Myoclonic Epilepsy (NextGen Sequencing Panel and Copy Number Analysis; 103 Genes) 2-4 Weeks $1, , 81404, 81406, NGS413 Congenital Myopathies (NextGen Sequencing Panel and Copy Number Analysis; 35 Genes) 2-4 Weeks $1, x2, NGS414 Noonan Syndrome (NextGen Sequencing Panel and Copy Number Analysis; 8 Genes) 2-4 Weeks $1, x3, , 81465, x1, x2, Ataxia/Episodic Ataxia Disorders (NextGen Sequencing Panel and Copy Number Analysis; 362 Genes + mtdna + SCA & HTT Repeat Expansion NGS Weeks $2, x2, x1, x1, 81479, Analysis) x8 NGS418 Actionable Epilepsy (NextGen Sequencing Panel and Copy Number Analysis; 70 Genes) 2-4 Weeks $1, x2, x3, x1, NGS419 Ataxia/Episodic Ataxia Disorders (NextGen Sequencing Panel and Copy Number Analysis; 362 Genes + mtdna + FRDA Repeat Expansion Analysis) 2-4 Weeks $2, NGS420 Ataxia/Episodic Ataxia Disorders (NextGen Sequencing Panel and Copy Number Analysis; 362 Genes + mtdna + SCA & FRDA Repeat Expansion Analysis) 2-4 Weeks $2, , 81465, x1, x2, x2, x1, x1, 81479, , 81465, x1, x2, x2, x1, x1, 81479, x8 NGS421 Congenital Muscular Dystrophies (NextGen Sequencing Panel and Copy Number Analysis; 28 Genes) 2-4 Weeks $1, , 81405, x4 NGS422 Limb-Girdle Muscular Dystrophy (NextGen Sequencing Panel and Copy Number Analysis; 29 Genes) 2-4 Weeks $1, , x4, x3, NGS423 Emery-Dreifuss Muscular Dystrophy (NextGen Sequencing Panel and Copy Number Analysis; 8 Genes) 2-4 Weeks $1, , 81408, 81404, 81405, NGS424 Duchenne/Becker Muscular Dystrophy (NextGen Sequencing Panel and Copy Number Analysis; 1 Gene) 2-4 Weeks $1, , NGS425 Microcephaly (NextGen Sequencing Panel and Copy Number Analysis; 297 Genes) 2-4 Weeks $1, , 81304, 81407, NGS426 Hydrocephalus (NextGen Sequencing Panel and Copy Number Analysis; 69 Genes) 2-4 Weeks $1, x2, x2, 81407, NGS427 X-linked Intellectual Disability (NextGen Sequencing Panel and Copy Number Analysis; 112 Genes) 2-4 Weeks $1, , 81471, 81243, 81244, 81302, 81304, 81404, 81405, NGS428 Tuberous Sclerosis (NextGen Sequencing Panel and Copy Number Analysis; 2 Genes) 2-4 Weeks $1, , NGS429 Familial Hemiplegic Migraine (NextGen Sequencing Panel and Copy Number Analysis; 5 Genes + mtdna) 2-4 Weeks $1, , x2, NGS430 Stroke (NextGen Sequencing Panel and Copy Number Analysis; 29 Genes + mtdna) 2-4 Weeks $1, x2, 81408, 81460, 81465, NGS431 Ataxia/Episodic Ataxia Disorders (NextGen Sequencing Panel and Copy Number Analysis; 362 Genes + mtdna + SCA Repeat Expansion Analysis) 2-4 Weeks $2, , 81465, x1, x2, x2, x1, x1, 81479, x7 15 of 16

16 NGS432 Comprehensive Intellectual Disability (NextGen Sequencing Panel and Copy Number Analysis; 902 Genes + Fragile X Repeat Expansion and Methylation) 2-4 Weeks $2, NGS445 Comprehensive Neuropathies (NextGen Sequencing Panel and Copy Number Analysis; 629 Genes + mtdna) 2-4 Weeks $2, , 81243, 81244, 81471, 81302, 81304, 81404, 81405, x , 81465, 81324, 81325, x3, x4, x3 NGS446 Dopa-Responsive Dystonia (NextGen Sequencing Panel and Copy Number Analysis; 5 Genes) 2-4 Weeks $1, TISSUE CULTURE TC01 Cryopreservation of Cells 7 Days $ TC03 Thaw & Expand Cells 3 Weeks $ TC04 Tissue Culture of Lymphocytes with EBV Transformation 4 Weeks $ TC05 Mycoplasma Testing of Cells 7 Days $ TC06 Tissue Culture of Skin Fibroblasts (Includes Skin Biopsy Processing) 3 Weeks $ of 16

PRICE AND TEST LIST August 24, 2018 (by Test Code)

PRICE AND TEST LIST August 24, 2018 (by Test Code) Test Code Test Description TAT Price 2018 CPT Codes WHOLE GENOME SEQUENCING WGS001 MNGenome TRIO Sequencing 2-6 Weeks Call 81425, 81426 x2 WGS003 MNGenome Proband Only Sequencing 2-6 Weeks Call 81425 WHOLE

More information

Subject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained:

Subject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained: TEST PERFORMED Whole exome sequencing (WES) with Focused Diagnostic Panel(s): Neuropathy, Leukodystrophy, Myopathy See below for a complete list of genes analyzed. RESULTS 1 sequence variant with potential

More information

MNG Exome Sequencing Test Request Form

MNG Exome Sequencing Test Request Form Whole Exome Sequencing MNG Exome Sequencing Test Request Form Note: Clinical Information and Consent Form are required for MNG Exome Orders. IMPORTANT: Please note if any additional samples will be shipped

More information

MNGenome Sequencing Test Request Form

MNGenome Sequencing Test Request Form MNGenome Sequencing Test Request Form Whole Whole Genome Exome Sequencing Note: Clinical Information and Consent Form are required for MNGenome Orders. *Please note if samples are shipping separately as

More information

COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS

COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS MITOCHONDRIAL DISORDERS NGS PANELS MITOCHONDRIAL DISORDERS NGS PANELS Name Test code Gene Name Mitome200-Nuclear 2086 (164 nuclear genes) AARS2, ACACA,

More information

Enabling Informed Clinical Decisions with Deep Insights. Routine Multi-gene Testing for Inherited Neuromuscular Disorders

Enabling Informed Clinical Decisions with Deep Insights. Routine Multi-gene Testing for Inherited Neuromuscular Disorders Enabling Informed Clinical Decisions with Deep Insights Routine Multi-gene Testing for Inherited Neuromuscular Disorders Introduction Multi-gene Testing for Inherited Neuromuscular Disorders Inherited

More information

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders NGS tests panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders UKGTN website lists 13 laboratories offering a total of 56 panel test UKGTN listed panel

More information

Mitochondrial Disorders Genetic Testing

Mitochondrial Disorders Genetic Testing Mitochondrial Disorders Genetic Testing A Comprehensive Guide 1 Introduction Mitochondrial disorders are a group of related, clinically diverse, genetic diseases with a prevalence of 1/5,000 to 1/8,500

More information

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5

Account # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5 Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition

More information

Genetic Testing for Neurologic Disorders

Genetic Testing for Neurologic Disorders Genetic Testing for Neurologic Disorders MP9497 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Pre- and post-test genetic counseling

More information

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels Targeted s and Methodology Details for Epilepsy/Seizure tic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Epilepsy/Seizure tic Panels Epilepsy Expanded Panel Epilepsy Expanded

More information

Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:

Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility: PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:

More information

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions: NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status

More information

Neurotransmitter Disorders.

Neurotransmitter Disorders. Neurotransmitter Disorders Simon.heales@gosh.nhs.uk Chemical Neurotransmission Neurotransmitters Substances that upon release from nerve terminals, act on receptor sites at postsynaptic membranes to produce

More information

Analysis of Neurotransmitters. Simon Heales

Analysis of Neurotransmitters. Simon Heales Analysis of Neurotransmitters Simon Heales HealeS@gosh.nhs.uk Tyrosine O 2 L-Dopa Dopamine HVA Tryptophan 5-HTP PLP Serotonin 5-HIAA Phenylalanine Tyrosine BH4 qbh2 BH2 CSF Sample Requirements Tube 1 Tube

More information

Referring Physician Information Name: (Last, First, Middle):

Referring Physician Information Name: (Last, First, Middle): Page 1 of 5 Patient Information Clinical Indication: Patient Name: (Last, First, Middle): DOB (M/D/Y): Sex: M F Guardian Name (for minor patients only): Address: City: State: ZIP: Phone: Ethnic Background

More information

Whole exome sequencing Gene package Epilepsy version 1,

Whole exome sequencing Gene package Epilepsy version 1, Whole Exome Sequencing Gene package Epilepsy, version 1, 8 4 2015 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina

More information

Analysis and interpretation of genetic NEUROLOGICAL DISORDERS

Analysis and interpretation of genetic NEUROLOGICAL DISORDERS , PH 1, POLG M, RAPSN, R CA, SGCB, SGC A3, SLC25A4, SLC5 1, SYNE2, SYT2, TAC NNT1, TNNT3, T N 4, TRIM63, TRIP4, AS39, VMA21, VPS S, ACADVL, ACTA1, AD 1, ANO5, ASCC1, ATP2A CACNA1S, CAPN3, CASQ P1, COL12A1,

More information

Epilepsy. Genetic Test Submission Guide. 2. Samples. 1. Forms. 3. Ship RESULTS. impactgenetics.com

Epilepsy. Genetic Test Submission Guide. 2. Samples. 1. Forms. 3. Ship RESULTS. impactgenetics.com Epilepsy Genetic Test Submission Guide 1. Forms 2. Samples Form 1d: If applicable Form 1b: Requisition Form Form 1a: Informed Consent 3. Ship RESULTS Impact Genetics, Dynacare 4-1100 Bennett Rd. Bowmanville,

More information

Neurogenetics User Manual

Neurogenetics User Manual Neurogenetics User Manual Page 1 of 21 Address: Neurogenetics Unit 6 th Floor, Institute of Neurology Institute of Neurology Queen Square, London WC1N 3BG Tel No: 020 344 84250 (ext 84250 if internal)

More information

Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS

Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS UNIVERSITY OF MINNESOTA PHYSICIANS OUTREACH LABS MOLECULAR DIAGNOSTICS (612) 273-8445 DATE: TIME COLLECTED: AM PM PCU/CLINIC: DIAGNOSIS (Dx) / DIAGNOSIS CODES (ICD-9) - OUTPATIENTS ONLY (1) (2) SPECIMEN

More information

REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First

REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First #: DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS & SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax#: 212-305-3986 REQUISITION FORM NOTE: ALL FORMS MUST

More information

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018 Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive

More information

Requisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection:

Requisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection: Reason for Referral: Diagnostic Testing: Affected Unaffected Carrier testing/known Family Mutation Name of index case in the family (include copy of report): Date of Birth: Relationship to this patient:

More information

Whole exome sequencing Gene package Epilepsy version 2,

Whole exome sequencing Gene package Epilepsy version 2, Whole Exome Sequencing Gene package Epilepsy, version 2, 1 7 2017 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina

More information

Request for expedited Result

Request for expedited Result London Health Sciences Centre Molecular Genetics Laboratories Requisition for DNA Testing DACC002 REV 20170815 AUTHORIZED SIGNATURE IS REQUIRED INCOMPLETE REQUESTS WILL BE BANKED Molecular Genetics Laboratory

More information

Whole exome sequencing Gene package Epilepsy version 3,

Whole exome sequencing Gene package Epilepsy version 3, Whole Exome Sequencing Gene package Epilepsy, version 3, 1 2 2018 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced on the Illumina

More information

theraseek Panel Gene List by Category

theraseek Panel Gene List by Category theraseek Panel Gene List by Category Gene Pathway/Function Association ACAT1 Alpha-methylacetoacetic aciduria Amino acid metabolism Pathway DHTKD1 Charcot-Marie-Tooth disease 2Q, axonal/2-aminoadipic

More information

Related Policies None

Related Policies None Medical policy MP 2.04.117 BCBSA Ref. Policy: 2.04.117 Last Review: 06/22/2017 Effective Date: 06/22/2017 Section: Medicine End Date: 06/26/2018 Related Policies None DISCLAIMER Our medical policies are

More information

Spieraandoeningen genpanel v2 (148 genen)

Spieraandoeningen genpanel v2 (148 genen) Spieraandoeningen genpanel v2 (148 genen) Gene ACADVL 99,8 VLCAD deficiency, 201475 ACTA1 99,1 Nemaline myopathy 3, autosomal dominant or recessive, 161800 Myopathy, actin, congenital, with excess of thin

More information

Bewegingsstoornisssen genpanel v1 (203 genen)

Bewegingsstoornisssen genpanel v1 (203 genen) Bewegingsstoornisssen genpanel v1 (203 genen) ABCB7 99,8 Anemia, sideroblastic, with ataxia, 301310 ABCD1 98,7 Adrenoleukodystrophy, 300100 Adrenomyeloneuropathy, adult, 300100 ABHD12 93,8 Polyneuropathy,

More information

Next-generation sequencing-based molecular diagnosis of neonatal hypotonia in Chinese

Next-generation sequencing-based molecular diagnosis of neonatal hypotonia in Chinese Title page Next-generation sequencing-based molecular diagnosis of neonatal hypotonia in Chinese Population Yan Wang 1, #,Wei peng 1,#, Hong-Yan Guo 3,4, Hui Li 3,4, Jie Tian 3,4, Yu-Jing Shi 3,4, Xiao

More information

variant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still

variant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still 157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can

More information

A rare case of muscular dystrophy with POMT2 and FKRP gene mutation. Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband

A rare case of muscular dystrophy with POMT2 and FKRP gene mutation. Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband A rare case of muscular dystrophy with POMT2 and FKRP gene mutation Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband Index : Congenital muscular dystrophy (CMD) Dystroglycanopathies Walker-Warburg

More information

Genetic Testing for Inherited Conditions

Genetic Testing for Inherited Conditions Genetic Testing for Inherited Conditions Policy Number: 2018-101 Effective Date: January 26, 2018 Review Date: January 26, 2018 Next Review Date: January 26, 2019 Important Information - Please Read Before

More information

Recent Advances in Neurology 2014: Neuromuscular Case Presentations

Recent Advances in Neurology 2014: Neuromuscular Case Presentations Recent Advances in Neurology 2014: Neuromuscular Case Presentations Jeffrey W. Ralph, MD Associate Clinical Professor Patient #1: Young woman with severe polyneuropathy 25 year-old woman Normal motor and

More information

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Roshanak Jazayeri, MD, PhD Assistant Professor of Medical Genetics Faculty of Medicine, Alborz University of Medical Sciences

More information

Movement Disorders Requisition Form

Movement Disorders Requisition Form Movement Disorders Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555 Fax:

More information

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.

More information

Strand Neuromuscular Disorders Test: Genes & Test Selection

Strand Neuromuscular Disorders Test: Genes & Test Selection 1 Strand Neuromuscular Disorders Test: Genes & Test Selection 2 Can the Strand Neuromuscular Disorders Test Be Offered for Prenatal Diagnosis? 3 Strand Neuromuscular Disorders Test: Genes & Test Selection

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Building 9 Contact: Dr Catherine Sturgeon BioQuarter Tel: +44 (0)131-2426885 Little France Road Fax: +44 (0)131-242-6882 E-Mail: c.sturgeon@ed.ac.uk Websites: http://edqas.org EH16 4UX Proficiency Testing

More information

Phosphorus. Diagnostics

Phosphorus. Diagnostics 14 32 6 32 Phosphorus Diagnostics 7 Genomics, illuminated. We focus on your peace of mind. Our expert-guided assay designs, powerful data analytics, and rigorous variant interpretation ensure accurate

More information

Presentation and investigation of mitochondrial disease in children

Presentation and investigation of mitochondrial disease in children Presentation and investigation of mitochondrial disease in children Andrew Morris Willink Unit, Manchester Mitochondrial function Carbohydrate Fat Respiratory chain Energy Mitochondria are the product

More information

Residual risks by ethnicity

Residual risks by ethnicity Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual

More information

CHRONIC MYELOGENOUS LEUKEMIA

CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases

More information

Childhood epilepsy: the biochemical epilepsies. Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary

Childhood epilepsy: the biochemical epilepsies. Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary Childhood epilepsy: the biochemical epilepsies Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary Definitions Epileptic Seizure Manifestation(s) of epileptic (excessive and/or

More information

OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018

OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018 OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018 Please note that there is a 15% surcharge for Non-NHS patients. Highly specialised services (HSS) are indicated. Note: This test

More information

Genetics & CMT Q&A Questions from the CMTA Genetics & CMT Discussion Forum

Genetics & CMT Q&A Questions from the CMTA Genetics & CMT Discussion Forum Genetics & CMT Q&A Questions from the CMTA Genetics & CMT Discussion Forum Presented by : Shawna Feely, MS, CGC & Carly Siskind MS, LCGC Is CMT a type of Muscular Dystrophy (MD)? Myopathy: a disease of

More information

Mail address: Surname and initials LUMC gebouw 2, Postal zone S-06-P. Administration: Sex Tel.: Fax:

Mail address: Surname and initials LUMC gebouw 2, Postal zone S-06-P. Administration: Sex Tel.: Fax: Mail address: Surname and initials LDGA Name spouse LUMC gebouw 2, Postal zone S-06-P Street name and number Einthovenweg 20, 2333 ZC, Leiden Postal code and city P.O. box 9600, 2300 RC Leiden Country

More information

CSF Investigations in patients with seizures. Dr Simon Olpin Sheffield Children s Hospital

CSF Investigations in patients with seizures. Dr Simon Olpin Sheffield Children s Hospital CSF Investigations in patients with seizures Dr Simon Olpin Sheffield Children s Hospital Background Epileptic seizures common feature in many inherited metabolic disorders particularly those involving

More information

Medical Policy Update

Medical Policy Update Medical Policy Update Summer 2017 Highlights of recent medical policy revisions as well as any new medical policies approved by Prevea360 Health Plan s Medical Policy Committee are shown below. The Medical

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:

More information

Riunione Regionale SIN Campania

Riunione Regionale SIN Campania Riunione Regionale SIN Campania Dott.ssa Maria Lieto Dipartimento di Neuroscienze, Università Federico II Napoli Salerno, 14 dicembre 2018 HEREDITARY ATAXIAS SCAs (35 genes) ARCAs (94 genes) Diagnosis?

More information

Egypt 90 Million People Power Seven Thousands Year Culture 29 Governorates

Egypt 90 Million People Power Seven Thousands Year Culture 29 Governorates Egypt 90 Million People Power Seven Thousands Year Culture 29 Governorates Recent advances in Molecular Medicine: Changing the practice of neurology Presentation by Nagwa Meguid, Prof. of Human Genetics

More information

devact TM Clinical Management Panel for Neurodevelopmental Disorders

devact TM Clinical Management Panel for Neurodevelopmental Disorders Amino acid disorder AMT Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GCSH Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GLDC Glycine encephalopathy

More information

Evaluation of the Hypotonic Infant and Child

Evaluation of the Hypotonic Infant and Child Evaluation of the Hypotonic Infant and Child Basil T. Darras, M.D. Neuromuscular Program Boston Children s Hospital Harvard Medical School Boston, MA, USA Classification and General Clinical Evaluation

More information

Whole Exome Sequencing (WES): Questions and Answers for Providers

Whole Exome Sequencing (WES): Questions and Answers for Providers Whole Exome Sequencing (WES): Questions and Answers for Providers 1. What is Whole Exome Sequencing?... 2 2. What is the difference between Whole Exome Sequencing (WES) and Whole Exome Sequencing Plus

More information

Genetic Testing for Limb-Girdle Muscular Dystrophies

Genetic Testing for Limb-Girdle Muscular Dystrophies Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Molecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY Tel: Fax:

Molecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY Tel: Fax: Molecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY 01234 Tel: 555-920-3333 Fax: 555-920-3334 www.moldxlaboratory.com Patient Name: Jane Doe Specimen type: Blood, peripheral DOB: 04/05/1990

More information

Summary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism

Summary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism Summary It is becoming clear that multiple genes with complex interactions underlie autism spectrum (ASD). A small subset of people with ASD, however, actually suffer from rare single-gene Important to

More information

CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands

CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE Bwee Tien Poll-The Amsterdam UMC The Netherlands FRAMEWORK OF PRINCIPALS 1. Problem-oriented clinical approach 2. Biomarkers in plasma, urine, CSF

More information

MEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG)

MEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with

More information

fetal akinesia deformation sequence (FADS) gene panel v6 (194 genen)

fetal akinesia deformation sequence (FADS) gene panel v6 (194 genen) fetal akinesia deformation sequence (FADS) gene panel v6 (194 genen) Gene % covered >30x Associated phenotype description and OMIM ID ACTA1?Myopathy, scapulohumeroperoneal, 616852 Myopathy, actin, congenital,

More information

National Metabolic Biochemistry Network Best Practice Guidelines. The Biochemical Investigation of Fits and Seizures for Inherited Metabolic Disorders

National Metabolic Biochemistry Network Best Practice Guidelines. The Biochemical Investigation of Fits and Seizures for Inherited Metabolic Disorders Introduction National Metabolic Biochemistry Network Best Practice Guidelines The Biochemical Investigation of Fits and Seizures for Inherited Metabolic Disorders These guidelines describe the differential

More information

Information for Service Users

Information for Service Users Molecular Genetics Laboratory Northern Genetics Service Northern Genetics Service Molecular Genetics Laboratory Information for Service Users 2017 Accredited Medical Laboratory Reference No: 2212 Laboratory

More information

Genomic Service List

Genomic Service List Document ID: MBG-C009 Effective Date: 10 Jan 018 Page: 1 of 5 WHOLE GENOME SEQUENCING Human Whole Genome Sequencing 1 HGG-15 Human Whole Genome Sequencing HGG-157 (FASTQ data only) WHOLE EXOME SEQUENCING

More information

General Approach to Genetic Testing

General Approach to Genetic Testing Protocol General Approach to Genetic Testing (20491) Medical Benefit Effective Date: 01/01/17 Next Review Date: 11/18 Preauthorization Yes Review Dates: 01/11, 01/12, 09/12, 05/13, 09/13, 09/14, 09/15,

More information

Index. Phys Med Rehabil Clin N Am 14 (2003) Note: Page numbers of article titles are in boldface type.

Index. Phys Med Rehabil Clin N Am 14 (2003) Note: Page numbers of article titles are in boldface type. Phys Med Rehabil Clin N Am 14 (2003) 445 453 Index Note: Page numbers of article titles are in boldface type. A Acid maltase deficiencies, electrodiagnosis of, 420, 422 Acquired peripheral neuropathy,

More information

4978 Santa Anita Ave Temple City, CA (p) (f)

4978 Santa Anita Ave Temple City, CA (p) (f) Patient Information Doe, Jane Sex: F MR#: FD Patient#: FT-PT00000 Accession: FT-00000 Test#: FT-00000 Specimen Type: Blood (EDTA) Collection Date: Aug 01, 2017 Partner Information Not Tested Accession:

More information

Advances in genetic diagnosis of neurological disorders

Advances in genetic diagnosis of neurological disorders Acta Neurol Scand 2014: 129 (Suppl. 198): 20 25 DOI: 10.1111/ane.12232 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ACTA NEUROLOGICA SCANDINAVICA Review Article Advances in genetic diagnosis

More information

Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing

Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing Karl V. Voelkerding, MD Professor of Pathology University of Utah Medical

More information

Genetic Diseases. SCPA202: Basic Pathology

Genetic Diseases. SCPA202: Basic Pathology Genetic Diseases SCPA202: Basic Pathology Amornrat N. Jensen, Ph.D. Department of Pathobiology School of Science, Mahidol University amornrat.nar@mahidol.ac.th Genetic disease An illness caused by abnormalities

More information

Centers for Medicare and Medicaid Services

Centers for Medicare and Medicaid Services Centers for Medicare and Medicaid Services Clinical Laboratory Fee Schedule Annual Laboratory Public Meeting June 25, 2018 Anthony Sireci, MD, Msc Association for Molecular Pathology Outline Germline Procedures

More information

Brain MRI in Mitochondrial Disorders: Correlating the Phenotype with the Genotype. Bindu Parayil Sankaran

Brain MRI in Mitochondrial Disorders: Correlating the Phenotype with the Genotype. Bindu Parayil Sankaran Brain MRI in Mitochondrial Disorders: Correlating the Phenotype with the Genotype Bindu Parayil Sankaran copyright Bindu Parayil Sankaran, Maastricht 2018 Printing: Datawyse Universitaire Pers Maastricht

More information

Clinical Laboratory Fee Schedule CY 2015 Updates June 9, 2014

Clinical Laboratory Fee Schedule CY 2015 Updates June 9, 2014 Clinical Laboratory Fee Schedule CY 2015 Updates June 9, 2014 Please note that this listing includes the most recent codes provided by the American Medical Association (AMA), and that it is subject to

More information

Additional new products may become commercially available. This is not meant to be a comprehensive list of all available products or tests.

Additional new products may become commercially available. This is not meant to be a comprehensive list of all available products or tests. Original Issue Date (Created): 11/26/2013 Most Recent Review Date (Revised): 8/17/2018 Effective Date: 10/1/2018 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS

More information

TREAT-NMD Care and Trial Sites Registry Information Chart

TREAT-NMD Care and Trial Sites Registry Information Chart TREAT-NMD Care and Trial Sites Registry Information Chart Below you find a list of the information that is asked in the CTSR of all registered neuromuscular disease sites. For more information please visit

More information

Mitochondrial disorders are among the most severe

Mitochondrial disorders are among the most severe NEUROLOGY GRAND ROUNDS Leigh Map: A Novel Computational Diagnostic Resource for Mitochondrial Disease Joyeeta Rahman, BSc, 1 Alberto Noronha, MSc, 2 Ines Thiele, PhD, 2 and Shamima Rahman, FRCP, PhD 1,3

More information

MP Genetic Testing for Limb-Girdle Muscular Dystrophies

MP Genetic Testing for Limb-Girdle Muscular Dystrophies BCBSA Ref. Policy: 2.04.132 Last Review: 04/30/2018 Effective Date: 04/30/2018 Section: Medicine Related Policies 2.04.86 Genetic Testing for Duchenne and Becker Muscular Dystrophy 2.04.105 Genetic Testing

More information

Patient information / fill out completely

Patient information / fill out completely Surname and initials Name spouse Street name and number Postal code and city Country Date of birth Sex Patient information / fill out completely PROCEDURE: Always consult us prior to sending material other

More information

What is Autism? Autism, Metabolic Diseases, and Immunizations. Metabolic Disorders in Autism Spectrum Disorder. The Mitochondrion 3/6/2009

What is Autism? Autism, Metabolic Diseases, and Immunizations. Metabolic Disorders in Autism Spectrum Disorder. The Mitochondrion 3/6/2009 What is Autism? Autism, Metabolic Diseases, and Immunizations Gregory M. Enns, M.B., Ch.B. Associate Professor of Pediatrics Director, Biochemical Genetics Program Stanford University Impairments in social

More information

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS A broad menu covering the vast majority of inherited metabolic disorders that are routinely tested as part of state newborn screening

More information

The mitochondrion and its disorders

The mitochondrion and its disorders 100 PRACTICAL NEUROLOGY H O W T O U N D E R S T A N D I T The mitochondrion and its disorders Patrick F. Chinnery Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and

More information

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA)

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) DEFICIENCY OF METABOLITE -HYPOXIA AND HYPOGLYCEMIA -HYPOVITAMINOSIS SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) -SPECIFIC CELL TYPE NEURONS>OLIGODENDROCYTES>ASTROCYTES -SPECIFIC BRAIN REGION PYRAMIDAL

More information

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Evolution of Genetic Testing Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Genetic Testing Chromosomal analysis Flourescent in situ hybridization (FISH) Chromosome

More information

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s) CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact

More information

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016.

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016. CENTOGENE Report: cases of rare diseases at CENTOGENE January 202 to June 206 Elucidating the basis for the link between the clinical phenotype and genotype correlation, and the factors contributing to

More information

Inherited Arrhythmia Syndromes

Inherited Arrhythmia Syndromes Inherited Arrhythmia Syndromes When to perform Genetic testing? Arthur AM Wilde February 4, 2017 Which pts should undergo genetic testing? SCD victims with a likely diagnosis Pts diagnosed with an inherited

More information

Table of Contents. Preface... xi. Part I: Introduction to Movement Disorders

Table of Contents. Preface... xi. Part I: Introduction to Movement Disorders Table of Contents Visit www.healthreferenceseries.com to view A Contents Guide to the Health Reference Series, a listing of more than 14,000 topics and the volumes in which they are covered. Preface...

More information

FRAMBU. Resource Centre for Rare Disorders

FRAMBU. Resource Centre for Rare Disorders FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory

More information

Whole exome sequencing Gene package Movement disorders version 3,

Whole exome sequencing Gene package Movement disorders version 3, Whole Exome Sequencing Gene package Movement disorders, version 3, 1 7 2017 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run

More information

Test Information Sheet

Test Information Sheet Neuromuscular Disorders (NMD) Panel Sequence Analysis and Exon-Level Deletion/Duplication* Testing of 80 Genes Panel Gene List: ACTA1, ANO5, ATP2A1, B3GALNT2, B3GNT1*, BAG3, BIN1, BICD2, CACNA1S, CAPN3,

More information

Contents 1 Normal Histology and Commonly Used Stains 2 Basic Pathologic Reactions

Contents 1 Normal Histology and Commonly Used Stains 2 Basic Pathologic Reactions Contents 1 Normal Histology and Commonly Used Stains.... 1 1.1 Cells of the Nervous System... 1 1.1.1 Neurons... 1 1.1.2 Astrocytes.... 2 1.1.3 Oligodendrocytes... 5 1.1.4 Schwann Cells... 5 1.1.5 Ependyma....

More information

Adult Metabolic Diseases Clinic 4 th Floor 2775 Laurel Street Vancouver, BC V5Z 1M9 Tel: Fax:

Adult Metabolic Diseases Clinic 4 th Floor 2775 Laurel Street Vancouver, BC V5Z 1M9 Tel: Fax: Adult Metabolic Diseases Clinic 4 th Floor 2775 Laurel Street Vancouver, BC V5Z 1M9 Tel: 604-875-5965 Fax: 604-875-5967 PROTOCOL FOR CSF COLLECTION FOR NEUROTRANSMITTERS WITH OR WITHOUT AMINO ACIDS Indications:

More information

Whole exome sequencing Gene package Movement disorders version 3.1,

Whole exome sequencing Gene package Movement disorders version 3.1, Whole Exome Sequencing Gene package Movement disorders, version 3.1, 22 11 2017 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced

More information

Limb Girdle Muscular Dystrophy

Limb Girdle Muscular Dystrophy Limb Girdle Muscular Dystrophy Reza Shervin Badv MD, Pediatric Neurologist Children s Medical Center Pediatrics Center of Excellence Tehran University of Medical Sciences Limb-girdle muscular dystrophies(lgmd)

More information

Developments in Laboratory Genetics

Developments in Laboratory Genetics Developments in Laboratory Genetics Rachel Butler rachel.butler@wales.nhs.uk The Impact of Genomics on Public Health Where are we now? Single gene disorders Core disorders Newborn screening (CF, MCAD)

More information

GENETICS IN HEREDITARY NEUROPATHY

GENETICS IN HEREDITARY NEUROPATHY GENETICS IN HEREDITARY NEUROPATHY ERNESTO ALONSO, SWETHA JASTI,MAZEN M.DIMACHKIE, RICHARD J. BAROHN, MELANIE GLENN, OMAR JAWDAT, JEFFREY STATLAND, LAURA HERBELIN, CONSTANTINE FARMAKIDIS,DUAA JABARI, MAMATHA

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:

More information